About: Risk assessment

Restoring trust and effectiveness in EU scientific advice

Today, more than ever, EU regulators must ensure that risk management decisions meet public demands for high standards of protection whilst simultaneously stimulating competitiveness and prosperity in Europe. Basing decisions on the best available science is the pre-condition for achieving these goals, argues Dirk Hüdig.
Health 09-02-2017

Commission must take action against endocrine disruptors

Reducing exposure to endocrine disrupting chemicals will benefit healthcare systems and economies as a whole, writes Christian Zahn.

Auditors’ report on biofuels calls for return to common sense

Will the report of the EU Court of Auditors (ECA) regarding the EU system for the certification of sustainable biofuels spark an outbreak of common sense within the Commission, asks Dick Roche.
Energy 19-10-2016

The EU’s dangerous biomass delusion

Bioenergy advocates claim that Europe’s forests are well managed and don’t contribute to global warming. Yet, biomass production in Europe is projected to rely more and more on materials that have a high risk of increasing greenhouse gas emissions, writes Linde Zuidema.
Health 01-09-2016

EU’s sunbed safety assessment clouded by bias

An upcoming assessment by a European Commission committee on the risks of UV radiation and sunbeds is hamstrung by in-built bias and a failure to comprehensively address all the issues, warns Frank Harbusch.
[epSos.de/Flickr]

What does an innovation agenda mean for consumers?

Innovation and consumer protection are not opposites. Indeed there is huge potential to use innovation to deliver safer products that benefit consumers, writes Monique Goyens.
Climate change 05-08-2016

Commission’s endocrine disruptor plan is illegal, inadequate and woefully late

European Commission draft rules to identify and ultimately ban endocrine disrupters are illegal because they clash with existing pesticide and biocide regulations, Alice Bernard writes. The environmental lawyer warned that EU judges could throw out the changes to the long-awaited scientific criteria for the chemicals.
Chemicals

The EU’s confused evidence processes for identifying endocrine disruptors

A group of scientists has written to the European Commission to voice concerns about burden of proof and confused evidence requirements to identify and classify endocrine disruptors under the PPP and Biocides Regulations.

EU glyphosate tantrum could leave people exposed to cancer risk

It is time for the European Commission to stop mucking about and act responsibly on glyphosate. If it grants a temporary extension it must include restrictions that minimise human exposure, writes Franziska Achterberg.

Chemicals ‘fitness check’ should improve EU legislation, not water it down

The scope of the European Commission’s Fitness Check on chemicals is limited to a comparison of the “hazard versus risk” approaches in chemicals legislation. This is misguided, writes Dolores Romano, who argues a hazard-based approach can help protect people and the environment while supporting innovation.
Agrifood 02-03-2016

Endocrine disruptors: ‘Better Regulation’ or better public health?

Endocrine disruptors pose a substantial risk to public health, yet the European Commission has dawdled time and again on introducing measures that would finally limit their use. Now is the time to put this right, write Genon Jensen and Michael Warhurst.
Contribute